Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro ConditionsJOURNAL OF PERSONALIZED MEDICINEIF32023-08-272OAAI
The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patientsARCHIVES OF MEDICAL SCIENCEIF3.32021-05-061OAAI
Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid MalignanciesMOLECULESIF4.62016-07-304OAAI
trans-Platinum(II) complex of 3-aminoflavone - synthesis, X-ray crystal structure and biological activities in vitroDALTON TRANSACTIONSIF3.32015-01-0115OAAI
Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignanciesEUROPEAN JOURNAL OF CANCERIF7.12014-10-0117PREAI
Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cellsEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72014-01-0129PREAI
Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus ErythematosusMEDIATORS OF INFLAMMATIONIF4.22014-01-0140OAAI
The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disordersANNALS OF HEMATOLOGYIF2.42013-05-018PREAI
Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemiaGENES CHROMOSOMES & CANCERIF2.82012-12-0831PREAI
Expression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemiaEUROPEAN JOURNAL OF CANCERIF7.12010-03-0150PREAI
CD38 Gene Polymorphisms Contribute to Genetic Susceptibility to B-Cell Chronic Lymphocytic Leukemia: Evidence from Two Case-Control Studies in Polish CaucasiansCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42009-03-0933OAAI
Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patientsANNALS OF HEMATOLOGYIF2.42007-09-1125PREAI
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphomaCANCERIF5.12006-09-1846PREAI